Litcius/Paper detail

Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

Tiago Torres, L. Puig, Ronald Vender, Charles Lynde, Stefano Piaserico, J.M. Carrascosa, Paolo Gisondi, E. Daudén, Curdin Conrad, Pedro Mendes‐Bastos, Paulo Ferreira, Luíz Leite, Justin D. Lu, Joana Valério, Manfredo Bruni, Francesco Messina, Alessia Nidegger, Mar Llamas‐Velasco, E. del Alcázar, Asfandyar Mufti, Kyra White, Giacomo Caldarola, Laetitia Teixeira, Paolo Romanelli, K. Desai, Spyridon Gkalpakiotis, Marco Romanelli, Jensen Yeung, Miguel Nogueira, Andrea Chiricozzi

2021American Journal of Clinical Dermatology116 citationsDOIOpen Access PDF

Topics & Concepts

MedicineSecukinumabIxekizumabUstekinumabPsoriatic arthritisInternal medicineRetrospective cohort studyPsoriasisHazard ratioProportional hazards modelOncologyDermatologyAdalimumabConfidence intervalDiseasePsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsDermatology and Skin Diseases